2022
DOI: 10.1080/02770903.2022.2144353
|View full text |Cite
|
Sign up to set email alerts
|

The impact of multistrains of probiotics on Th17-related cytokines in patients with asthma: a randomized, double-blind, placebo-controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…Multiple studies have also shown Treg cell percentage and their suppressive activity were significantly decreased in SARS-CoV-2 patients [ 33 ]. It has been suggested that TNF-α and IL-6 could reduce suppressive activity in Tregs by preventing of TGF-β and FoxP3 expression [ 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Multiple studies have also shown Treg cell percentage and their suppressive activity were significantly decreased in SARS-CoV-2 patients [ 33 ]. It has been suggested that TNF-α and IL-6 could reduce suppressive activity in Tregs by preventing of TGF-β and FoxP3 expression [ 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…93 Supplementation with a probiotic mixture of multiple Lactobacilli, B. longum, and Streptococcus thermophilus in adults with asthma resulted in an improvement of lung function, a reduction in several inflammatory markers and an increase in regulatory markers. [94][95][96] However, in longitudinal studies, supplementation with L. reuteri, L. rhamnosus, or B. lactis or a mix of Lactobacilli and Bifidobacteria to pregnant women in the last month of pregnancy, 3-6 months postpartum, and after birth to their newborns till 6 months to 2 years of age did not induce a difference in asthma incidence at school age. [97][98][99][100] In conclusion, the in vivo interventions described above only seem to influence asthma symptoms in children above 3 years and adults and do not prevent asthma development, when given during pregnancy and in newborns.…”
Section: Interventi On S Tud Ie Smentioning
confidence: 91%
“…A study in which 3–14 years old asthmatics were supplemented with a mixture of Lactobacillus and Bifidobacterium for 16 weeks found a reduction in asthma exacerbations 93 . Supplementation with a probiotic mixture of multiple Lactobacilli, B. longum , and Streptococcus thermophilus in adults with asthma resulted in an improvement of lung function, a reduction in several inflammatory markers and an increase in regulatory markers 94–96 . However, in longitudinal studies, supplementation with L. reuteri, L. rhamnosus , or B. lactis or a mix of Lactobacilli and Bifidobacteria to pregnant women in the last month of pregnancy, 3–6 months postpartum, and after birth to their newborns till 6 months to 2 years of age did not induce a difference in asthma incidence at school age 97–100 …”
Section: Intervention Studiesmentioning
confidence: 99%